Related Experiment Video
Updated: Dec 8, 2025

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
Fibrillation and molecular characteristics are coherent with clinical and pathological features of 4-repeat tauopathy
Alexander Sandberg1, Helen Ling2, Marla Gearing3
1Department of Physics Chemistry and Biology, Linköping University, Linköping, Sweden.
Abstract:
Microtubule Associated Protein Tau (MAPT) forms proteopathic aggregates in several diseases. The G273R tau mutation, located in the first repeat region, was found by exome sequencing in a patient who presented with dementia and parkinsonism. We herein return to pathological examination which demonstrated tau immunoreactivity in neurons and glia consistent of mixed progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) features. To rationalize the pathological findings, we used molecular biophysics to characterize the mutation in more detail in vitro and in Drosophila. The G273R mutation increases the aggregation propensity of 4-repeat (4R) tau and alters the tau binding affinity towards microtubules (MTs) and F-actin. Tau aggregates in PSP and CBD are predominantly 4R tau. Our data suggest that the G273R mutation induces a shift in pool of 4R tau by lower F-actin affinity, alters the conformation of MT bound 4R tau, while increasing chaperoning of 3R tau by binding stronger to F-actin. The mutation augmented fibrillation of 4R tau initiation in vitro and in glial cells in Drosophila and showed preferential seeding of 4R tau in vitro suggestively causing a late onset 4R tauopathy reminiscent of PSP and CBD.
Insights
The G273R tau mutation promotes the aggregation of 4-repeat tau, a key factor in tauopathies like progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). This mutation alters tau
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Microtubule Associated Protein Tau (MAPT) aggregates in neurodegenerative diseases.
- The G273R tau mutation was identified in a patient with dementia and parkinsonism.
- Progressive Supranuclear Palsy (PSP) and Corticobasal Degeneration (CBD) are characterized by 4-repeat (4R) tau aggregates.
Purpose of the Study:
- To investigate the molecular mechanisms underlying the G273R tau mutation's role in tauopathies.
- To characterize the in vitro and in vivo effects of the G273R mutation on tau aggregation and binding properties.
Main Methods:
- Exome sequencing identified the G273R mutation.
- Pathological examination of patient brain tissue.
- Molecular biophysics studies in vitro.
- Drosophila models were used to study tau aggregation and seeding.
Main Results:
- The G273R mutation increases 4R tau aggregation propensity.
- Altered binding affinity of tau to microtubules (MTs) and F-actin.
- The mutation promotes 4R tau fibrillation in vitro and in glial cells.
- Preferential seeding of 4R tau aggregates was observed.
Conclusions:
- The G273R mutation contributes to 4R tauopathy by altering tau's interaction with MTs and F-actin.
- This mutation may cause late-onset tauopathies resembling PSP and CBD.
- Understanding these mechanisms could inform therapeutic strategies for tauopathies.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Microtubule Associated Proteins (MAPs)

